Imatinib vs Nivolumab

## Imatinib vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Imatinib** and **Nivolumab**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Imatinib — 18 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Imatinib — C29H31N7O; Nivolumab — N/A.

**Molecular Weight**: Imatinib — 493.6030 g/mol; Nivolumab — N/A.

**Type**: Imatinib — Small molecule; Nivolumab — Antibody.